jueves, 14 de noviembre de 2013

Cancer Diagnosis Program (CDP)

Cancer Diagnosis Program (CDP)

Laser scan of DNA on a microarray chip with intensities of the different color dots (yellow being least and red the most) indicating the quantity of the DNA in the scan

Omics Tests and Clinical Trials

NCI and academic collaborators have developed 30 criteria to evaluate the readiness of complex molecular tests to guide decision-making during clinical trials. Using mathematical models, these “omics” tests study genes, proteins, and other types of molecules taken from a biological sample. Omics tests potentially can predict which therapies are most likely to be beneficial.

No hay comentarios:

Publicar un comentario